Evidence map›Paper›PMID 31234714›Full record

ArticleCell cycle (Georgetown, Tex.)2019

Gremlin is a potential target for posterior capsular opacification.

Bo Ma, Ruihua Jing, Jie Liu, Tiantian Qi, Cheng Pei

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Smurf1 Modulates Smad Signaling Pathway in Fibrotic Cataract Formation.Investigative ophthalmology & visual science · 2024
    Article
  5. Consilience and unity in ocular anterior segment research.International journal of ophthalmology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Fibronectin has multifunctional roles in posterior capsular opacification (PCO).Matrix biology : journal of the International Society for Matrix Biology · 2020
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Bo Maa Department of Ophthalmology , The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , Shaanxi , China.
Ruihua Jinga Department of Ophthalmology , The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , Shaanxi , China.
Jie Liua Department of Ophthalmology , The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , Shaanxi , China.
Tiantian Qia Department of Ophthalmology , The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , Shaanxi , China.
Cheng Peia Department of Ophthalmology , The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , Shaanxi , China.
First Affiliated Hospital of Xi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ActinsAnimalsCapsule OpacificationCell LineCell MovementCell ProliferationCollagen Type IEpithelial CellsEpithelial-Mesenchymal TransitionFemaleFibronectinsGene SilencingHumansIntercellular Signaling Peptides and ProteinsMaleMAP Kinase Signaling SystemActa2 protein, ratActinsCollagen Type IFibronectinsGREM1 protein, humanGrem2 protein, ratIntercellular Signaling Peptides and ProteinsProteinsRNA, Small InterferingSmad Proteins, Receptor-RegulatedTransforming Growth Factor beta2epithelial mesenchymal transitionextracellular matrix synthesisGremlinposterior capsular opacification

Identifiers

PMID31234714
PMCPMC6649605
OpenAlexW2955868484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.